What do the 2026 Surviving Sepsis Campaign guidelines say about the use of ferritin in sepsis management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

The Surviving Sepsis Campaign 2026 Guidelines Do Not Address Ferritin

There are no 2026 Surviving Sepsis Campaign guidelines for adult sepsis management, and the most recent adult guidelines (2016) do not include any recommendations regarding ferritin measurement or use in sepsis. The evidence provided only contains the 2016 Surviving Sepsis Campaign guidelines 1, 2, 1, 2, 1, which make no mention of ferritin in their recommendations.

What the Guidelines Actually Say

The 2016 Surviving Sepsis Campaign guidelines focus on:

  • Initial resuscitation with crystalloid fluids (30 mL/kg within 3 hours)
  • Early antimicrobial therapy (within 1 hour)
  • Vasopressor support targeting MAP ≥65 mmHg
  • Source control
  • Nutritional support recommendations

Notably absent from these guidelines is any recommendation about measuring or using ferritin levels for diagnosis, prognosis, or treatment decisions in sepsis.

Pediatric Guidelines Context

The 2026 pediatric Surviving Sepsis Campaign guidelines 3 introduce updates for children but do not specifically address ferritin measurement as a recommended biomarker. The pediatric guidelines emphasize lactate measurement at initial assessment, but ferritin is not mentioned as part of the core recommendations.

The Evidence Gap

While recent research demonstrates that:

  • Elevated ferritin (>504-828 ng/mL) correlates with increased mortality in sepsis 4, 5, 6
  • Ferritin combined with other markers may improve prognostic accuracy 7, 5
  • Hyperferritinemia (≥4420 ng/mL) defines macrophage activation-like syndrome (MALS) with worse outcomes 4

These findings have not yet been incorporated into official Surviving Sepsis Campaign recommendations. The guidelines remain focused on established interventions with stronger evidence for mortality reduction.

Clinical Implications

In the absence of guideline recommendations, ferritin measurement in sepsis remains a clinical judgment decision rather than a standard of care. The research suggests potential utility for risk stratification, but this has not translated into actionable treatment algorithms endorsed by the Surviving Sepsis Campaign.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.